                         SEQUENCE LISTING

<110>  SEDERMA
 
<120>  TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC 
       USE

<130>  PEPT JEU 2 PCT

<150>  FR2011743
<151>  2020-11-17

<160>  63    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  1

Lys Thr Thr Lys Ser 
1               5   


<210>  2
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  2

Gly Gln Pro Arg 
1               


<210>  3
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  3

Val Gly Val Ala Pro Gly 
1               5       


<210>  4
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  4

Lys Thr Thr Lys Ser 
1               5   


<210>  5
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  5

Val Gly Val Ala Pro Gly 
1               5       


<210>  6
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  6

Leu Leu Leu Glu 
1               


<210>  7
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  7

Leu Lys Leu Glu 
1               


<210>  8
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  8

Leu Glu Leu Glu 
1               


<210>  9
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  9

Leu Asp Leu Glu 
1               


<210>  10
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  10

Lys Lys Leu Glu 
1               


<210>  11
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  11

Lys Leu Leu Glu 
1               


<210>  12
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  12

Lys Glu Leu Glu 
1               


<210>  13
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  13

Lys Asp Leu Glu 
1               


<210>  14
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  14

Glu Glu Leu Glu 
1               


<210>  15
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  15

Glu Leu Leu Glu 
1               


<210>  16
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  16

Glu Lys Leu Glu 
1               


<210>  17
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  17

Glu Asp Leu Glu 
1               


<210>  18
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  18

Asp Asp Leu Glu 
1               


<210>  19
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  19

Asp Leu Leu Glu 
1               


<210>  20
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  20

Asp Lys Leu Glu 
1               


<210>  21
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  21

Asp Glu Leu Glu 
1               


<210>  22
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  22

Leu Leu Glu Leu 
1               


<210>  23
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  23

Leu Leu Glu Lys 
1               


<210>  24
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  24

Leu Leu Glu Glu 
1               


<210>  25
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  25

Leu Leu Glu Asp 
1               


<210>  26
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  26

Lys Leu Glu Lys 
1               


<210>  27
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  27

Lys Leu Glu Leu 
1               


<210>  28
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  28

Lys Leu Glu Glu 
1               


<210>  29
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  29

Lys Leu Glu Asp 
1               


<210>  30
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  30

Glu Leu Glu Glu 
1               


<210>  31
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  31

Glu Leu Glu Leu 
1               


<210>  32
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  32

Glu Leu Glu Lys 
1               


<210>  33
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  33

Glu Leu Glu Asp 
1               


<210>  34
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  34

Asp Leu Glu Asp 
1               


<210>  35
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  35

Asp Leu Glu Leu 
1               


<210>  36
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  36

Asp Leu Glu Lys 
1               


<210>  37
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  the amino acid is either unmodified or modified by acylation 
       -CO-R1, or -SO2-R1 or by a biotinoyl, R1 = a 1 to 24C, alkyl, 
       aryl, aralkyl, alkylaryl, alkoxy, saccharide or aryloxy group

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  the amino acid is either unmodified or modified in OR1, NH2, NHR1
       or NR1R2, R1 and R2 = a 1 to 24C, alkyl, aryl, aralkyl, 
       alkylaryl, alkoxy, saccharide or aryloxy group, R1 and R2 being 
       chosen independently

<400>  37

Asp Leu Glu Glu 
1               


<210>  38
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  38

Leu Lys Leu Glu 
1               


<210>  39
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  39

Glu Leu Glu Asp 
1               


<210>  40
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  40

Arg Ser Arg Lys 
1               


<210>  41
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  41

Gly Gln Pro Arg 
1               


<210>  42
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  42

Lys Thr Phe Lys 
1               


<210>  43
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  43

Lys Thr Ala Lys 
1               


<210>  44
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  44

Lys Ala Tyr Lys 
1               


<210>  45
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  45

Lys Phe Tyr Lys 
1               


<210>  46
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  46

Lys Thr Ser Lys Ser 
1               5   


<210>  47
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa being either a Proline P or a Leucine L

<400>  47

Tyr Gly Gly Phe Xaa 
1               5   


<210>  48
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  48

Gly Lys Thr Thr Lys Ser 
1               5       


<210>  49
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa being Trp, Phe, Tyr, Tic, 7-hydroxy-Tic or Tpi

<400>  49

His Leu Asp Ile Ile Xaa 
1               5       


<210>  50
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  50

Lys Thr Phe Lys 
1               


<210>  51
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  51

Lys Thr Ala Lys 
1               


<210>  52
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  52

Lys Ala Tyr Lys 
1               


<210>  53
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  53

Lys Phe Tyr Lys 
1               


<210>  54
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  54

Lys Thr Phe Lys 
1               


<210>  55
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  55

Lys Thr Ser Lys Ser 
1               5   


<210>  56
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa being either a Proline P or a Leucine L.

<400>  56

Tyr Gly Gly Phe Xaa 
1               5   


<210>  57
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa being Trp, Phe, Tyr, Tic, 7-hydroxy-Tic or Tpi

<400>  57

His Leu Asp Ile Ile Xaa 
1               5       


<210>  58
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  58

Gly Lys Thr Thr Lys Ser 
1               5       


<210>  59
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Acetylation on the N-terminal end

<400>  59

Glu Glu Met Gln Arg Arg 
1               5       


<210>  60
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  60

Tyr Ala Gly Phe Leu 
1               5   


<210>  61
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  61

Ala His Ser His 
1               


<210>  62
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  62

Ser Ile Lys Val Ala Val 
1               5       


<210>  63
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  63

Gly Pro Gln Gly Pro Gln 
1               5       


